Unexpected Trends Boost Enrollment in Tobacco Cessation Trial, Offering Hope for More Diverse Clinical Research
Barcelona, Spain – September 6, 2025 – A new subanalysis of the Screen ASSIST tobacco cessation clinical trial (NCT03611881) is challenging conventional wisdom about clinical trial participation, revealing surprisingly higher enrollment rates among groups historically underrepresented in research. The findings, presented this week at the World Conference on Lung cancer, suggest a pathway to improving diversity in clinical trials and ultimately reducing health disparities in lung cancer and other smoking-related illnesses.
The Screen ASSIST trial integrated tobacco cessation support into a lung cancer screening program, offering counseling and nicotine replacement therapy alongside connections to vital social resources. Researchers assessed enrollment patterns,